# Safflower Oil Cholesterol Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/safflower-oil-cholesterol-randomized-trial-evidence-review
Category: evidence-review
Summary: Safflower Oil Cholesterol Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass 
Last reviewed: 2026-06-26
Reviewed by: Migaku Evidence Review
# Safflower Oil Cholesterol Randomized Trial: What the Evidence Says

## Quick Answer

Safflower Oil Cholesterol Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 randomized trial.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Effects of Canola Oil on Hepatic and Cardiometabolic Markers in Non‐Alcoholic Fatty Liver Disease: A Systematic Review and Meta‐Analysis | systematic review | 1 | 2026-04-01 | PMC13092728 |
| Effect of Dietary Linoleic Acid Intake on Eicosapentaenoic Acid Status and Lipoxygenase-Mediated Oxylipin Biosynthesis in Healthy Adults: A Randomized Controlled Trial | randomized trial | 2 | 2026-06-04 | 10.3390/nu18111814 |

## What The Sources Report

- Effects of Canola Oil on Hepatic and Cardiometabolic Markers in Non‐Alcoholic Fatty Liver Disease: A Systematic Review and Meta‐Analysis [Ege Gündüz K (2026); evidence level 1]
- Increased dietary LA has contributed to a pervasive imbalance in dietary-6 relative to-3 polyunsaturated fatty acids (PUFA) that has been proposed to affect the incidence and progression of chronic diseases. [Sergeant Susan (2026); evidence level 2]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. There is trial evidence in the current set, but population and intervention details still matter. For safflower oil cholesterol randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Ege Gündüz K (2026). Effects of Canola Oil on Hepatic and Cardiometabolic Markers in Non‐Alcoholic Fatty Liver Disease: A Systematic Review and Meta‐Analysis. PMCID: PMC13092728. https://pmc.ncbi.nlm.nih.gov/articles/PMC13092728/
- Sergeant Susan (2026). Effect of Dietary Linoleic Acid Intake on Eicosapentaenoic Acid Status and Lipoxygenase-Mediated Oxylipin Biosynthesis in Healthy Adults: A Randomized Controlled Trial. DOI: 10.3390/nu18111814. PMCID: PMC13259401. PMID: 42280457. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13259401/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.